Field not found.

Found 1304 Results
Page 51 of 131


Conyers L, Richardson L, Datti P, Koch L, Misrock M A critical review of health, social, and prevention outcomes associated with employment for people living with HIV AIDS Educ Prev PubMed


Ayu AP, el-Guebaly N, Schellekens A, de Jong C, Welle-Strand G, Small W, Wood E, Cullen W, Klimas J Core addiction medicine competencies for doctors, an international consultation on training Subst Abus PubMed


Argento E, Strathdee SA, Tupper K, Braschel M, Wood E, Shannon K Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting BMJ Open PubMed


Klimas J, Small W, Ahamad K, Cullen W, Mead A, Rieb L, Wood E, McNeil R Barriers and facilitators to implementing addiction medicine fellowships: a qualitative study with fellows, medical students, residents and preceptors Addict Sci Clin Pract PubMed


Olding M, Enns B, Panagiotoglou D, Shoveller J, Harrigan PR, Barrios R, Kerr T, Montaner JSG, Nosyk B A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015 J Int AIDS Soc PubMed


Panagiotoglou D, Krebs E, Min JE, Olding M, Ahamad K, Ti L, Montaner JSG, Nosyk B Initiating HCV treatment with direct acting agents in opioid agonist treatment: when to start for people co-infected with HIV? Int J Drug Policy PubMed


Knight R, Roux P, Vilotitch A, Marcellin F, Rosenthal E, Esterle L, Boué F, Rey D, Piroth L, Dominguez S, Sogni P, Salmon-Ceron D, Spire B, Carrieri MP; ANRS CO13-HEPAVIH Study Group Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort Addiction PubMed


Mitra S, Rachlis B, Scheim A, Bardwell G, Rourke SB, Kerr T Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian city Harm Reduct J PubMed


Wild TC, Pauly B, Belle-Isle L, Cavalieri W, Elliott R, Strike C, Tupper K, Hathaway A, Dell C, MacPherson D, Sinclair C, Karekezi K, Tan B, Hyshka E Canadian harm reduction policies: a comparative content analysis of provincial and territorial documents, 2000-2015 Int J Drug Policy PubMed


Nosyk B, Zang X, Min JE, Krebs E, Lima VD, Milloy MJ, Shoveller J, Barrios R, Harrigan PR, Kerr T, Wood E, Montaner JSG Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada: 1996–2013: a modelling study Lancet HIV PubMed


BC Centre on Substance Use
4th Floor, 1190 Hornby Street,
Vancouver BC, V6Z 2K5

E: [email protected] | T: (778) 945-7616

24/7 Addiction Clinician Support Line: (778) 945-7619

ACTOC and POATSP: [email protected]




Copyright © 2026, BC Centre on Substance Use